Back to Search
Start Over
Preclinical pharmacokinetic/pharmacodynamic models to predict synergistic effects of co-administered anti-cancer agents
- Source :
- Cancer chemotherapy and pharmacology. 66(2)
- Publication Year :
- 2009
-
Abstract
- Pharmacokinetic/pharmacodynamic (PK/PD) models have been shown to be useful in predicting tumor growth rates in mouse xenografts. We applied novel PK/PD models to the published anticancer combination therapies of tumor growth inhibition to simulate synergistic changes in tumor growth rates. The parameters from the PK/PD model were further used to estimate clinical doses of the combination.A PK/PD model was built that linked the dosing regimen of a compound to the inhibition of tumor growth in mouse xenograft models. Two subsequent PK/PD models were developed to simulate the published tumor growth profiles of combination treatments. Model I predicts the tumor growth curve assuming that the effect of two anticancer drugs, AZD7762 and irinotecan, is synergistic when given in combination. Model II predicts the tumor growth curve assuming that the effect of co-administering flavopiridol and irinotecan is maximally synergistic when dosed at an optimal interval.Model I was able to account for the synergistic effects of AZD7762 following the administration of irinotecan. When Model II was applied to the antitumor activity of irinotecan and flavopiridol combination therapy, the modeling was able to reproduce the optimal dosing interval between administrations of the compounds. Furthermore, Model II was able to estimate the biologically active dose of flavopiridol recommended for phase II studies.The timing of clinical combination therapy doses is often selected empirically. PK/PD models provide a theoretical structure useful in the design of the optimal clinical dose, frequency of administration and the optimal timing of administration between anticancer agents to maximize tumor suppression.
- Subjects :
- Cancer Research
Combination therapy
Drug Evaluation, Preclinical
Mice, Nude
Thiophenes
Pharmacology
Toxicology
Irinotecan
Mice
Pharmacokinetics
Piperidines
Predictive Value of Tests
Antineoplastic Combined Chemotherapy Protocols
medicine
Animals
Humans
Urea
Pharmacology (medical)
Tumor growth
PK/PD models
Cell Proliferation
Flavonoids
Models, Statistical
business.industry
Cell growth
Cancer
Drug Synergism
medicine.disease
Antineoplastic Agents, Phytogenic
Xenograft Model Antitumor Assays
Growth Inhibitors
Genes, cdc
Oncology
Pharmacodynamics
Camptothecin
business
Algorithms
Neoplasm Transplantation
medicine.drug
Subjects
Details
- ISSN :
- 14320843
- Volume :
- 66
- Issue :
- 2
- Database :
- OpenAIRE
- Journal :
- Cancer chemotherapy and pharmacology
- Accession number :
- edsair.doi.dedup.....3664f1f074df03f4f3f1d0d2ced390ac